S Yurdakul

Summary

Affiliation: Istanbul University
Country: Turkey

Publications

  1. ncbi request reprint A double-blind trial of colchicine in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, University of Istanbul, Turkey
    Arthritis Rheum 44:2686-92. 2001
  2. ncbi request reprint Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome
    V Hamuryudan
    Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Turkey
    Clin Exp Rheumatol 30:S32-4. 2012
  3. ncbi request reprint Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study
    F Moral
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 13:493-5. 1995
  4. ncbi request reprint A reappraisal of amyloidosis in Behçet's syndrome
    M Melikoglu
    Department of Rheumatology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 40:212-5. 2001
  5. ncbi request reprint Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome
    I Fresko
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol 23:S67-70. 2005
  6. ncbi request reprint A cost analysis of Behcet's syndrome in Turkey
    N Sut
    Department of Biostatistics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 46:678-82. 2007
  7. ncbi request reprint Secondary amyloidosis in progressive systemic sclerosis
    G E Pamuk
    Cerrahpasa Medical School, University of Istanbul, Turkey
    Clin Rheumatol 20:285-7. 2001
  8. ncbi request reprint Fibrinolytic activity and d-dimer levels in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Istanbul, Turkey
    Clin Exp Rheumatol 23:S53-8. 2005
  9. doi request reprint EULAR recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 67:1656-62. 2008
  10. doi request reprint Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 68:1528-34. 2009

Collaborators

Detail Information

Publications10

  1. ncbi request reprint A double-blind trial of colchicine in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, University of Istanbul, Turkey
    Arthritis Rheum 44:2686-92. 2001
    ..We reassessed the effect of colchicine in Behçet's syndrome in a study conducted among a larger group of patients for 2 years...
  2. ncbi request reprint Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome
    V Hamuryudan
    Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Turkey
    Clin Exp Rheumatol 30:S32-4. 2012
    ..The numbers and recurrence rates of mucocutaneous manifestations can be highly variable among patients with Behçet's syndrome (BS) but it is not known whether these differences influence the disease course at the long-term...
  3. ncbi request reprint Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study
    F Moral
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 13:493-5. 1995
    ..05). There were also no differences in the mean numbers of acetaminophen tablets used or in the CRP and ESR levels between the two groups. We conclude that azapropazone is not effective in controlling the arthritis of Behçet's syndrome...
  4. ncbi request reprint A reappraisal of amyloidosis in Behçet's syndrome
    M Melikoglu
    Department of Rheumatology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 40:212-5. 2001
    ..To evaluate the clinical features and outcome of patients with Behçet's syndrome (BS) and amyloidosis and to assess the associated risk factors...
  5. ncbi request reprint Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome
    I Fresko
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol 23:S67-70. 2005
    ..Increased as well as normal levels have been reported in Behçet's syndrome (BS). We reassessed the level of IgG and IgA ASCA antibodies in BS and in a group of diseased and healthy controls...
  6. ncbi request reprint A cost analysis of Behcet's syndrome in Turkey
    N Sut
    Department of Biostatistics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 46:678-82. 2007
    ..Behçet's syndrome (BS), a common chronic inflammatory disease in Turkey, results in considerable morbidity and increased mortality. We aimed to estimate its direct and indirect costs...
  7. ncbi request reprint Secondary amyloidosis in progressive systemic sclerosis
    G E Pamuk
    Cerrahpasa Medical School, University of Istanbul, Turkey
    Clin Rheumatol 20:285-7. 2001
    ..He died from massive upper gastrointestinal bleeding caused by oesophageal telangiectasia...
  8. ncbi request reprint Fibrinolytic activity and d-dimer levels in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Istanbul, Turkey
    Clin Exp Rheumatol 23:S53-8. 2005
    ..We have studied tissue-type plasminogen activator (t-PA) and its inhibitor (PAI-1), and d-dimer levels in BS patients with and without thrombosis both in the acute and chronic phases along with suitable diseased and healthy controls...
  9. doi request reprint EULAR recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 67:1656-62. 2008
    ..To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion...
  10. doi request reprint Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 68:1528-34. 2009
    ....